Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
It is primarily available for research purposes, and its use in humans carries regulatory and safety considerations
In receptor-deficient systems, the peptide does not produce measurable changes in lipolytic signaling, supporting the conclusion that its effects are mediated through adrenergic pathway engagement rather than direct hormone receptor activation
Researchers often study BPC 157 and TB 500 alongside growth hormone secretagogues such as CJC-1295 and Ipamorelin, growth hormone-releasing hormone analogues like Tesamorelin and Sermorelin, and IGF-1 pathway compounds like IGF-1 LR3 each offering complementary insights into anabolic, regenerative, and metabolic signaling
Modulatory Effects of BPC 157 on Vasomotor Tone and the Activation of Src-Caveolin-1-Endothelial Nitric Oxide Synthase Pathway, Hsieh MJ, Lee CH, Chueh HY, Chang GJ, Huang HY, Lin Y, Pang JS, Scientific Reports, 2020 Oct 13;10(1):17078.
The number of samples scales with batch size, and all must meet specification before the batch is released
